We Are EnteraSense

We are dedicated to adding value to the management and diagnosis of Upper GI bleeding hence improving patient outcomes.



EnteraSense Limited is a medical device sensor diagnostic company founded in 2015 by Donal Devery, Dr. Marvin Ryou, and Dr. Chris Thompson of Brigham and Women’s Hospital/Harvard Medical School in the United States.

Location: Mervue Galway

The company is based in Galway, Ireland and has a licensed technology agreement from Brigham and Women’s Hospital/Harvard Medical School which enables the company to develop devices for diagnosing and monitoring Upper Gastric Bleeds.
Jan 2018

Initial Seed Funding

EnteraSense raises an initial seed funding round of €1m.

Irish medtech startup gets €2.5m grant boost

Courtesy Charlie Taylor - Irish Times Jan 09, 2019 EnteraSense, a Galway-based medical technology start-up has secured €3.5 million in funding through a combination of private seed investment and an EU Horizon

FDA Submission

May 2020 EnteraSense Submitted to the FDA.
June 2020

Product Manufactuing

Manufacturing line has been developed, agreed and tested. Initial product is currently under manufacturing for release in October 2020.
Q4 2020

First In Human & Clinical Trials

Protocols & approvals have been obtained from the relevant competent authorities.
Q1 2021

FIH - Czech Republic

Successful completion of FIH in Q1 2021